A patient of Scleroderma presents with acute respiratory distress. Chest X-ray shows B/L reticular basilar shadows. What is the next line of investigation in this patient?
First, scleroderma is an autoimmune disease that can cause fibrosis in various organs, including the lungs. The reticular shadows suggest interstitial lung disease, which is common in scleroderma. The differential for acute respiratory distress in this context might include acute interstitial pneumonia or pulmonary fibrosis.
The next investigation after a chest X-ray showing reticular shadows would typically be a CT scan. High-resolution CT (HRCT) of the chest is more sensitive and specific than a regular X-ray. It can better assess the extent and pattern of interstitial lung disease, which is crucial for diagnosis and management.
The options might include spirometry, bronchoscopy, or maybe a different imaging modality. Spirometry is useful for obstructive vs restrictive patterns but isn't the first step after an abnormal X-ray. Bronchoscopy might look for infection or other causes but isn't the initial step. So, HRCT makes sense here.
Clinical pearl: In scleroderma patients with pulmonary symptoms, HRCT is essential for evaluating interstitial lung disease and differentiating it from other causes like pulmonary hypertension. Remember that scleroderma can lead to both ILD and pulmonary arterial hypertension, so imaging is key.
**Core Concept**
Scleroderma commonly causes interstitial lung disease (ILD) due to fibroblast activation and collagen deposition. Bilateral reticular basilar shadows on chest X-ray suggest ILD, which requires high-resolution computed tomography (HRCT) for definitive diagnosis and characterization.
**Why the Correct Answer is Right**
HRCT of the chest is the gold standard for evaluating interstitial lung disease. It can detect ground-glass opacities, reticular abnormalities, and honeycombing, which are hallmark features of ILD in scleroderma. This modality provides detailed anatomical information to guide treatment decisions and assess disease severity.
**Why Each Wrong Option is Incorrect**
**Option A:** Pulmonary function tests (PFTs) assess restrictive or obstructive patterns but do not visualize interstitial changes directly.
**Option B:** Bronchoscopy with bronchoalveolar lavage is useful for infectious or granulomatous causes but is not first-line for ILD.
**Option C:** Echocardiography evaluates pulmonary hypertension, a complication of scleroderma, but does not diagnose ILD itself.
**Clinical Pearl / High-Yield Fact**
In scleroderma patients with respiratory symptoms, HRCT is critical to distinguish ILD (which responds to immunosuppressants) from pulmonary arterial hypertension (requiring vasodilators). Remember the mnemonic: **Scleroderma → Skin, Scleroderma, and Lungs (S3L)**.
**Correct Answer: D. High-resolution CT (HRCT) of the chest**